Bank of Montreal’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bank of Montreal’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,524	Closed	-$609K	–	4336
2015 Q1	$609K	Sell	3,524 -23,934	-87%	-$3.51M	﹤0.01%	1837
2014 Q4	$3.16M	Buy	27,458 +2,460	+10%	+$298K	﹤0.01%	1214
2014 Q3	$3.91M	Sell	24,998 -14,297	-36%	-$2.07M	﹤0.01%	1185
2014 Q2	$4.85M	Sell	39,295 -74,531	-65%	-$8.24M	0.01%	1094
2014 Q1	$11.8M	Sell	113,826 -79,205	-41%	-$8.11M	0.02%	597
2013 Q4	$17.4M	Sell	193,031 -59,060	-23%	-$4.71M	0.02%	422
2013 Q3	$16.9M	Buy	252,091 +69,371	+38%	+$4.78M	0.03%	374
2013 Q2	$12.1M	Buy	+182,720	New	+$10.4M	0.02%	436

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Bank of Montreal's SLXP Position: Q2 2015 in Review

Bank of Montreal sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 3,524 shares — an estimated $609K sold.

Bank of Montreal first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $17.4M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Bank of Montreal reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Bank of Montreal sold 3,524 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $609K.
Bank of Montreal first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Bank of Montreal's SALIX PHARMACEUTICALS LTD DEL position peaked at $17.4M in Q4 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Bank of Montreal's 13F filing for Q2 2015, filed 4 Aug 2015.